Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 316

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 6
Chunk 316
---
westschweiz, Switzerland and a Master in law at University of Zurich, Switzerland.
Florence Allouche Aknin, Director

Florence Allouche Aknin has served as a Director since January 2024. From July 2022 to October 2023, Dr. Allouche Aknin served as the Chairperson of the board of directors of Genomic Vision S.A. and from July 2016 to October 2020 she served as the President and Chief Executive Officer of SparingVision. Dr. Allouche Aknin is a Doctor of Pharmacy and holding a Master’s in Business Administration, began her career as a biologist at AP-HP (Greater Paris Hospitals), managing the tech transfer office for 16 years and creating 75 start-ups. Dr. Allouche Aknin is an expert and mentor at the Paris incubators and has represented French technology internationally. She is a Professor of Pharmacy at the University Paris City and an elected member of the French National Academy of Pharmacy. She is also the President and Founder of Myrpharm Advisors, a start-up studio for the biopharmaceutical industry. In addition, in 2022, Dr. Allouch Aknin launched Sorbonne Venture, a €100M fund dedicated to health technology. She is also Chairwoman of the Board of Directors for PepKon, a French biotechnology company. Among her many awards, Dr. Allouche Aknin was elected “Woman of the Year 2017” by the French financial magazine La Tribune, Women’s trajectory Award 2018 by HEC Paris, and Mercure Entrepreneurs Award 2019 by HEC Paris.
Olivier Samuel, Director

Olivier Samuel has served as our director since October 2024. He has also served as a director of Kadimastem since December 2020. Mr. Samuel brings over 25 years of experience in product sales in the medical space. Mr. Samuel is also a professional mediator since March 2021. From January 1997 until December 2019, Mr. Samuel was the CEO of Adomsante in France. Mr. Samuel has a master’s in business administration and management from Emlyon Business School and the Lille School of Health Engineers.

177

Olivier Samuel, Director

Mr. Samuel has served as director of Kadimastem since January 2020. Mr. Samuel brings over 25 years of experience in product sales in the medical space. From March 2021